- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02165501
Jena Sepsis Registry (JenaSepsisReg)
November 24, 2016 updated by: Jochen Gensichen, MD, MA, MPH, University of Jena
Jena Sepsis Registry - a Sepsis-registry for Long Term Outcomes
Despite the burden of severe sepsis and septic shock deficiencies in the quality of sepsis management are recognized.
Investigators present a population-based registry with easy feasibility as part of German Center for Sepsis Control & Care (CSCC).
All ICU patients of the Jena University Hospital, Germany will be screened for inclusion (severe sepsis or septic shock).
Baseline data on ICU- and hospital care will be extracted from patient records at ICU discharge.
The primary outcome is change in all-cause mortality from baseline to follow up at 6, 12, 24, 36, 48 and 60 months after diagnosis of sepsis.
Follow-up data will be collected from the primary care provider of the patient.
The registry may provide valid data on quality in sepsis care.
Study Overview
Status
Unknown
Study Type
Observational
Enrollment (Actual)
1995
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jena, Germany, 07743
- Jena University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients will be selected from Jena University Hospital, Germany
Description
Inclusion Criteria:
- Patients treated in one of the ICUs will be enrolled if they were 18 years or older and fulfill the diagnostic criteria of severe sepsis or septic shock (ICD-10-GM, R65.0, R65.1) (19), (20).
- Diagnosis of severe sepsis or septic shock requires the following criteria: a microbiologically documented and/or clinically evident infection, at least two of the four criteria of the systemic inflammatory response syndrome (SIRS) and at least one new organ dysfunction, remote from the site of infection.
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
all cause mortality
Time Frame: change from baseline to 6,12, 24, 36, 48 and 60 months after ICU discharge
|
based on data from hospital records as well as patient records of the primary care provider.
|
change from baseline to 6,12, 24, 36, 48 and 60 months after ICU discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (ACTUAL)
December 1, 2015
Study Completion (ANTICIPATED)
December 1, 2019
Study Registration Dates
First Submitted
June 11, 2014
First Submitted That Met QC Criteria
June 13, 2014
First Posted (ESTIMATE)
June 17, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
November 28, 2016
Last Update Submitted That Met QC Criteria
November 24, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3218-08/11
- FZ 01 E0 1002 (OTHER_GRANT: Federal Ministry of Education and Research (BMBF))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Sepsis or Septic Shock (ICD-10-GM, R65.0, R65.1)
-
Yonsei UniversityCompletedSevere Sepsis or Septic ShockKorea, Republic of
-
Centre Hospitalier Universitaire DijonCompletedFluid Resuscitation | Severe Sepsis or Septic ShockFrance
-
Assistance Publique - Hôpitaux de ParisCompletedSevere Sepsis or Septic Shock in Pediatric Intensive Care UnitFrance
-
Rennes University HospitalUnknownSevere Sepsis or Septic Shock
-
Brigham and Women's HospitalCompletedSevere Sepsis or Septic ShockUnited States
-
Dr. Damon ScalesCanadian Institutes of Health Research (CIHR); Sunnybrook Research InstituteRecruitingSevere Sepsis or Septic ShockCanada
-
University Hospital, Clermont-FerrandCompletedSeptic Shock | Acute Respiratory Distress Syndrome | Acute Lung Injury | Severe Sepsis | Mechanical VentilationFrance
-
Mahidol UniversityCompletedSeptic Shock | Acute Respiratory Distress Syndrome | Acute Lung Injury | Severe SepsisThailand